Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

The claims of Ifenprodil helping low O2 patients and the IL-6 affects were somehow dropped with the 'no phase 3' trials for Ifenprodil.

This was a company decision, the FDA did Not say it was futile/ineffective or had safety issues, Right?

Both these were claimed to be at significant data levels. Many felt that there were follow thru possibilities. I guess AGN is supporting the IL-6 Tumor data from these results to combine with the work from Dr North.?.

Sure we may have to accept the issues of cost and waning COVID needs for not advancing to a phase 3 trial. But, IMO, we should expect a publication of the data that WAS found. Good or Not.

Ifenprodil for ARDS / IPF is related to the data collected from the COVID trial, IMO. Such a huge investment of Company/shareholder money and Time deserves a publication of results.

Maybe there is Something that can be marketed from this Ifenprodil Trial... Seems just like the Breathalyzer after Dr Yost left, just dropped instead of an effort to progress or profit from all the work. Certainly less info and respect being shown to investors.